OXFORD, England--(BUSINESS WIRE)--At the American Society of Human Genetics (ASHG) 2025 industry session on 16th October, Oxford Nanopore Technologies will share its latest developments in enabling ...

The Oxford Nanopore PromethION devices enable high-output, high-throughput sequencing of native DNA or RNA samples on demand. PromethION 24 (P24) and PromethION 48 (P48), operating up to 24 or 48 flow ...

The PromethION is Oxford Nanopore Technologies' largest sequencing device, capable of delivering many terabases of data, in real time, from a single run. Hear how teams across a broad range of ...

Oxford Nanopore Technologies announced the early access launch of its all-in-one desk top sequencing device, the PromethION 2 Integrated (P2i) to complete its PromethION product range. Engineered with ...

OXFORD, UK / ACCESSWIRE / December 2, 2021 /\Highlights include release of new "Kit 12" and R10.4 flow cells for >Q20 (>99%) raw read and around Q30 (99.9%) Duplex sequencing accuracy, and the new ...

At present, most metagenomic surveys rely on high-output platforms such as Illumina. However, the short reads generated by these platforms limit specificity of taxonomic assignment and result in ...

Oxford Nanopore Technologies is rolling out a new version of its high-throughput benchtop DNA sequencer with the goal of providing genetic data to a wide variety of researchers and scientific areas.

OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies Ltd, the company behind the only portable real-time DNA/RNA sequencer, MinION, has raised £100M ($140M) in new investment. Funds were ...

Detailed price information for Oxford Nanopore Technologies Plc (ONTTF) from The Globe and Mail including charting and trades.